the future of
play

The Future of Community Based Testing Bernadette Jackson Point of - PowerPoint PPT Presentation

The Future of Community Based Testing Bernadette Jackson Point of Care Manager Naas General Hospital Accreditation ISO 15189 Inspection M OKane 2012 Quality in Testing Process Internal Quality Staffing Controls - Medical


  1. The Future of Community Based Testing Bernadette Jackson Point of Care Manager Naas General Hospital

  2. Accreditation ISO 15189 Inspection M O’Kane – 2012

  3. Quality in Testing Process  Internal Quality  Staffing Controls - Medical Scientists  External Quality (Chief, Specialists, Senior, staff grade) Assurance - Biochemist - NEQAS - WEQAS - Pathologists - IEQAS - DEQAS - RIQAS ISO 15189 – Annual Inspection – INAB (Quality Management System)

  4. Patient Confidence in Treatment

  5. Advances since Teamworks - 2007  Laboratory Accreditation is widespread – ISO 15189  Analyses are provided within externally inspected services - INAB  Sample collection systems improved  IT Connectivity between GP and laboratory services.  IT Connectivity within hospital networks - reports  Linked LIS e.g. Maternity Services  MedLIS Project  SLA’s within networks  24/7

  6. Key Health Trends - 2018 F =83; M=79

  7. Naas General Hospital – Area 7 24 244 + Population 250,000

  8. Teamworks Report -2007  Self Care - patient empowerment  Local Care - General practice - Primary Care - Community - Ambulance services

  9. Point of Care Testing Using point-of-care testing in a managed way, in acute hospitals, in local healthcare settings and in the patient’s home, wherever it is clinically appropriate and cost effective.

  10. Healthcare Centres (HSE)

  11. Point of Care Test - 2004 “ An analytical test undertaken by a member of the healthcare team or by a non medical individual in a setting distinct from a normal hospital laboratory”

  12. Point of Care Testing - Where ??

  13. Inspection X Accreditation ISO 15189 /22870 M O’Kane – AACC - 2012

  14. Tests at Point of Care  pH, pCO 2 , pO 2  Na + ; K + ; Cl - ; Creat; Lipids; Glucose; Ketone; Lactate; Troponin; C-reactive protein; HbA1c, Natriuretic peptides, hCG; PTH; TBil, Pro Calcitonin  Hb; INR  Urinalysis; Streptoccal infection; HIV; Hepatitis; Flu  Pregnancy Tests ;Toxicology  Occult Blood

  15. Devices and Test Systems

  16. Analytical Methods Mark et.al. – 2010 – Chem Soc Review

  17. PST INR - NGH Anticoagulation Clinic Inspection X Accreditation ISO 15189:2012 22870:2016

  18. Accreditation Anticoagulation ISO:15189 Clinic INR = 4.5 M O’Kane – AACC - 2012

  19. Point of Care Testing - Operators – Laboratory Staff – Medical Staff – Nursing staff – Physiotherapist – Pharmacist, GP, Practice Nurse, EMT, Fire Crew – Others e.g. Health Screening – Patient (PST)

  20. AntiCoagulation Service

  21. Training Delivery – acute setting  POCT Manager  Supplier  POCT + supplier  Link trainers  Non scientific colleagues  None !! (agency staff)

  22. POCT Testing Strengths Weaknesses  Speed Uniquely vulnerable to error  Operators - non laboratory staff   Patient interaction Trainers  Equipment – fit for purpose ?  Change Tx  - Comparability with laboratory  Diagnosis tests at various levels including for ongoing patient management  Reduction in OPD Traceability: user, patient,  reagents clinic, hospital and Erroneous results  other contacts IT connectivity and middleware  management capability Speed 

  23. Quality & Risk ??  “However, these  Pre- Analytical Error instruments are often - Demographic entry operated by staff not - Infusion site trained in laboratory  Analytical medicine and hence - Different Units: HI; LO prone to errors in the - Lower sensitivity / cut analytical phase (as off points / imprecision opposed to the - Interference: laboratory where the analytical phase has haemolysis, bilirubin, the least errors”  Post Analytical - Florkowski et. al. (2017) - Records - handwritten, Critical Reviews in Lab paper, no electronic Medicine record

  24. Point of Care Testing - Weaknesses  IQC: composition, practice, protocols  Historic practices/ equipment  Pre analytical factors (Kazmierzak , Clin Chem 2011 )  Lack of understanding of the quality processes in result generation  Out of hours support – training, repair

  25. Point of Care Testing - Assumptions  Quality Management System in Situ: - Governance - Users trained & competent - Equipment is checked daily for performance - Equipment and reagents are regulated, maintained, history  Results are Verified: - Lab comparability for both guidelines and ongoing investigations/ monitoring - System of investigation/ reporting errors/ inconsistencies  No pre- analytical, analytical, post analytical errors

  26. Recalibration of Strips lots required and faulty strip lot replaced

  27. Teamworks Report - 2007 We use the term point-of-care testing to mean laboratory tests performed by non-laboratory staff, (typically medical and nursing) at or near the site of patient care in the primary care sector and outside the main laboratory in hospital departments. The types, test repertoire, training, deployment and quality assurance of point-of-care test analysers is controlled by the Laboratory Medicine Service, responsible for implementing a national Point-of-Care Testing strategy.

  28. ISO Standards - POCT  “testing that is performed near or at the site of a patient with the result leading to possible change in the care of the patient” 15189 22870 - 2012 -2016 INAB Inspection

  29. Regulation – Point of Care Testing  France – ISO 15189/22870 – 2020  Ireland – 5 sites – SJH; Mater; Coombe; BonSecours, Tallaght  UK – UKAS – CPA to ISO - 2018 (ongoing)  USA - POCT tests currently waived Waived tests include test systems cleared by the FDA for home use and those tests approved for waiver under the CLIA criteria . Although CLIA requires that waived tests must be simple and have a low risk for erroneous results, this does not mean that waived tests are completely error-proof.

  30. Point of Care – Guidance Documents National POCT Consultative Group

  31. POCT- Community  The state of point-of-care testing: a european perspective. Larsson et al. (2015) - Upsala Journal of Medical Sciences “When POCT enters the community, issues concerning management and oversight, training, quality assurance, and documentation are all greatly amplified”

  32. March ‘18

  33. Type 2 Diabetes – Aim of Model of Integrated Care • Prevent or delay the onset of Type 2 diabetes • Improve the delivery of diabetes care to people with type 2 diabetes across all four levels of care i.e. specialist inpatient, specialist ambulatory care, specialist support to Primary Care and chronic disease prevention and management in Primary Care, all supported by patient self management. • save the lives, eyes and limbs of people with diabetes • ensure care is in line with the quality, access and cost objectives of the National Clinical Programme for Diabetes

  34. Analyses – Type 2 DM  HbA1c ≤ 53 mmol/L (3 per year) (IFCC method)  LDL ≤ 2.5 mmol/L (annual)  HDL ≥ 1.0 / 1.3 mmol/L (m/f)  Trig ≤ 1.7 mmol/L  FBC, Creatinine, ACR, TFT

  35. HbA1c Interferences

  36. Glucometer ? Blood Glucose  Monitoring - Targets - Technique - Hand Hygiene - Meter calibration & storage - Sharps disposal - Testing frequency Meter performance ?? 

  37. Results Haem/ Coag Clin Chem  15:12  15:12 - Hb =13.4 Grm/dl - Na + = 140 mmol/L - Platelets = 279 - K + = 4.2 mmol/L - PT >83.2 - Urea =12.5 mmol/L - INR >8.0 - Creat =131 umol/L - APTT > 182 - Fibrinogen <0.4

  38. Results  15:30 - Hb = 7.9 G/L ( POCT Blood Gas ) - Na + = 145 mmol/L; K + = 2.6 mmol/L  15:51 Tx. RCC x 2; Vitamin K (10mgs IV)  17:30 – 18:30 Large Melaena - RCC x 1, FEIBA (4000 IU), Fibrinogen (4 Grms)

  39. Results  19:18 – (Haem /Coag) - Hb =15.0 G/L - Platelets = 177 - INR >8.0 - APTT > 182 - Fibrinogen <0.4 - Na + = 143 mmol/L; K + =4.4 mmol/L (Clin Chem)  00:00 – Hb = 15.8 G/dl (Haem)

  40. Community POCT - Recommendations  National policies for POCT Testing  POCT Team  Oversight by a Coordinator- Senior Scientist  Procedures for performance of analysis  Operator training, competency assessment  IQC & EQA  Adverse Incident Investigation & Reporting  Business case & risk assessment  Quality Management System  Inspection

  41. Ter Avest et al. (2015) Point-of-care troponinT is inferior Patient to high-sensitivity troponin T for ruling out acute myocardial infarction in the emergency department. European Journal of Emergency Medicine “ POCT is laboratory testing and must be treated as such, which includes an understanding of the entire testing process from the pre-analytical phase to the post- analytical phase for anyone performing testing” – Shaw J. (2016) – Pract. Lab Medicine

  42. POCT Staffing – Acute Settings 2018 500 - 1010 beds 10 9 8 7 6 5 4 3 2 1 0 1 2 3 4 5 6 7 8 9

Recommend


More recommend